Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Solazyme Inc    SZYM   US83415T1016

SOLAZYME INC (SZYM)

23
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/24/2014 10/27/2014 10/28/2014 10/29/2014 10/30/2014 Date
6.54(c) 6.39(c) 7.02(c) 6.92(c) 6.93(c) Last
839 762 710 758 1 024 708 814 898 878 552 Volume
+1.55% -2.29% +9.86% -1.42% +0.14% Change
More quotes
Company
Solazyme, Inc. is a renewable oil company, which is engaged in the industrial biotechnology.The company's technology allows algae to produce oils and biomaterials in standard fermentation facilities.Its oils and biomaterials are used for bio-fuel production and replacements for fossil petroleum and... 
Sector
Renewable Fuels
Calendar
11/05Earnings Release
Surperformance© rating of Solazyme Inc
Trading Rating : Investor Rating :
More about the company
Chart SOLAZYME INC
Duration : Period :
Solazyme Inc Technical Analysis Chart | SZYM | US83415T1016 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 88,8 M
EBIT 2014 -110 M
Net income 2014 -146 M
Debt 2014 214 M
Yield 2014 -
Sales 2015 275 M
EBIT 2015 -50,0 M
Net income 2015 -63,7 M
Debt 2015 339 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 8,54x
EV / Sales 2015 3,22x
Capitalization 545 M
More Financials
Latest news on SOLAZYME INC
10/23 SOLAZYME : Appoints David Cole as Strategic Advisor
10/17 AMYRIS : EPA honors Calif. companies Amyris and Solazyme for using green chemist..
10/16 AMYRIS : U.S. EPA honors Calif. companies Amyris and Solazyme for using green ch..
10/14 SOLAZYME : Names David Cole a Strategic Advisor
10/10 SOLAZYME : Announces Transition of David Cole to Strategic Advisor
10/09 SOLAZYME : Change in Directors or Principal Officers (form 8-K)
10/09 SOLAZYME : Announces Appointment of Former DuPont CFO Gary Pfeiffer to the Board..
10/09 SOLAZYME : to Announce Third Quarter 2014 Financial Results on November 5, 2014
10/09 SOLAZYME : Announces Transition of David Cole to Strategic Advisor
10/09 Nasdaq stocks posting largest percentage decreases
10/02 SOLAZYME : Assigned Patent
09/12 SOLAZYME : to Participate in the 5th Annual Credit Suisse Small & Mid Cap Confer..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF